Back to News
Market Impact: 0.35

All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy

PHR
Corporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsHealthcare & BiotechInvestor Sentiment & Positioning
All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy

Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), driven by a significant 41.5% increase in its Zacks Consensus Estimate for the fiscal year ending January 2026 over the past three months. This upgrade, based on Zacks' methodology which correlates earnings estimate revisions with near-term stock performance, positions PHR in the top 20% of Zacks-covered stocks, indicating potential for near-term price appreciation and market-beating returns.

Analysis

Phreesia (PHR) has received a rating upgrade to a Zacks Rank #2 (Buy), a move predicated entirely on a significant upward revision in its earnings estimates. The Zacks Consensus Estimate for the company's fiscal year ending January 2026 has improved by a notable 41.5% over the past three months, signaling a substantial positive shift in sell-side analyst sentiment regarding its earnings trajectory. This quantitative-driven upgrade places PHR in the top 20% of stocks covered by the Zacks system, which historically correlates with near-term outperformance. It is critical to note, however, that despite this material improvement in outlook, the consensus EPS forecast for fiscal 2026 remains at a loss of -$0.17 per share. This figure is also unchanged from the prior year's reported result, indicating that the improved estimates are narrowing the projected loss rather than forecasting a turn to profitability. The primary implication is potential near-term buying pressure driven by institutional investors who adjust valuations based on such estimate revisions.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo